论文信息 - A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. - 字舞流文

A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.

E. Surwit | S. Aristizabal | S. Weiner | D. Alberts | K. Deatherage-Deuser

[1] M. Spaulding. Chapter 9 – INDUCTION CHEMOTHERAPY IN THE TREATMENT OF HEAD AND NECK CANCER: SUNY BUFFALO AND VAMC EXPERIENCE , 1985 .

[2] J. Herman,et al. Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study. , 1984, International journal of radiation oncology, biology, physics.

[3] M. Friedlander,et al. The integration of chemotherapy into the management of locally advanced cervical cancer: a pilot study. , 1984, Gynecologic oncology.

[4] S. Shapshay,et al. Combination of cis‐platinum and bleomycin prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced squamous cell carcinoma of the head and neck , 1982, Cancer.

[5] Nelson Jh,et al. Surgical treatment of early cervical cancer. , 1982 .

[6] M. Perry,et al. Chemotherapy of cervical carcinoma. , 1982, Seminars in oncology.

[7] D. Alberts,et al. Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix. , 1982, Cancer clinical trials.

[8] G. Fletcher,et al. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. , 1975, Radiology.